A brief screening tool to assess the risk of contracting HIV infection among active injection drug users

Journal of Addiction Medicine

Volumn 9, Issue 3, 2015, Pages 226-232

  Smith, Dawn K ^a   Pan, Yi ^a   Rose, Charles E ^a   Pals, Sherri L ^a   Mehta, Shruti H ^b   Kirk, Gregory D ^b   Herbst, Jeffrey H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIV; IDUs; PrEP; Risk; Screening

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; ASSESSING RISK OF CONTRACTING HIV INJECTION DRUG USERS; COHORT ANALYSIS; COMPOSITE INJECTION SCORE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INJECTION DRUG USER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING; SENSITIVITY AND SPECIFICITY; UNITED STATES; ADVERSE EFFECTS; COCAINE DEPENDENCE; COMPLICATION; HEROIN DEPENDENCE; HIV INFECTIONS; MIDDLE AGED; NEEDLE SHARING; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE;

ADULT; COCAINE-RELATED DISORDERS; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES;

EID: 84942804665     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000123     Document Type: Article

References (34)

1. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367(5):399-410. doi:10.1056/NEJMoa1108524.
2. Bruce RD, Kresina TF, McCance-Katz EF. Medication-Assisted treatment and HIV/AIDS: Aspects in treating HIV-infected drug users. AIDS 2010;24(3):331-340.
3. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States 2007-2010. HIV Surveillance Supplemental Report 2012a;17(4) Available at http://www.cdc.gov/hiv/pdf/statistics hssr vol 17 no 4.pdf. Accessed February 26 2015
4. Centers for Disease Control and Prevention. HIV infection and HIV-Associated behaviors among injecting drug users-20 cities, United States, 2009. MMWR Morb Mortal Wkly Rep 2012b;61(8):133-138.
5. Centers for Disease Control and Prevention. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep 2012c;61(RR-5):1-40.
6. Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2011. HIV Surveillance Report 2013;23. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.
7. Centers for Disease Control and Prevention. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States States-2014: A clinical practice guideline. Available at http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf. Published May 14, 2014. Accessed March 18, 2015.
8. Chan AWK, Pristach EA, Welte JW. Detection by the CAGE of alcoholism or heavy drinking in primary care outpatients and the general population. J Substance Abuse 1994;6(2):123-135. doi:10.1016/s0899-3289(94)90157-0.
9. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381(9883):2083-2090. doi:10.1016/S0140-6736(13)61127-7.
10. Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the mini-mental state examination by age and educational level. JAMA 1993;269(18):2386-2391. doi:10.1001/jama.1993.03500180078038.
11. Des Jarlais DC, Marmor M, Friedmann P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health 2000;90(3):352.
12. Edelman EJ, Fiellin DA. Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine. Am J Prev Med 2013;44(1 suppl 2):S86-S90. doi:10.1016/j.amepre.2012.09.035.
13. Efron B. Estimating the error rate of a prediction rule-improvement on cross-validation. J Am Stat Assoc 1983;78(382):316-331. doi:10.2307/22 88636.
14. Evans JL, Tsui JI, Hahn JA, et al. Mortality among young injection drug users in San Francisco: A 10-year follow-up of the UFO study. Am J Epidemiol 2012;175(4):302-308. doi:10.1093/Aje/Kwr318.
15. Fendrich M, Mackesy-Amiti ME, Johnson TP. Validity of self-reported substance use in men who have sex with men: comparisons with a general population sample. Ann Epidemiol 2008;18(10):752-759. doi:10.1016/j.annepidem.2008.06.001.
16. Gaynes BN, West SL, Ford CA, et al. Screening for suicide risk in adults: A summary of the evidence for the U.S. preventive services task force. Annals of Internal Medicine 2004;140(10):822-835.
17. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363(27):2587-2599. doi:10.1056/NEJMoa1011205.
18. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15(4):361-387. doi:10.1002/(SICI)1097-0258(19960229)15:4 3.0.CO;2-4.
19. Jones J, Stephenson R, Smith DK, et al. Acceptability and willingness among men who have sex with men (MSM) to use a tablet-based HIV risk assessment in a clinical setting. Springerplus 2014;3(1):708.
20. Lansky A, Finlayson T, Johnson C, et al. Estimating the number of persons who inject drugs in the United States by meta-Analysis to calculate national rates of HIV and Hepatitis C virus infections. PLoS One 2014;9(5):e97596. doi:10.1371/journal.pone.0097596.
21. Magnus M, Kuo I, Phillips G II, et al. Differing HIV risks and prevention needs among men and women Injection Drug Users (IDUs) in the district of Columbia. J Urban Health 2013;90(1):157-166. doi:10.1007/s11524-012-9687-5.
22. Mathers BM, Degenhardt L, Bucello C, et al. Mortality among people who inject drugs: A systematic review and meta-Analysis. Bull World Health Organ 2013;91(2):102-123. doi:10.2471/Blt.12.108282.
23. Meader N, Semaan S, Halton M, et al. An international systematic review and meta-Analysis of multisession psychosocial interventions compared with educational or minimal interventions on the HIV sex risk behaviors of people who use drugs. AIDS Behav 2013;17(6):1963-1978. doi:10.1007/s10461-012-0403-y.
24. Sharp LK, Lipsky MS. Screening for depression across the lifespan: A review of measures for use in primary care settings. Am Fam Phys 2002;66(6):1001-1008.
25. Smith DK, Pals SL, Herbst JH, et al. Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr 2012;60(4):421-427. doi:10.1097/QAI.0b013e318256b2f6.
26. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and noninjecting drug users: current trends and implications for interventions. Curr HIV/AIDS Reports 2010;7(2):99-106.
27. Substance Abuse and Mental Health Services Administration. Injection drug use and related risk behaviors, 2006-2008. National Survey on Drug Use and Health: The NASDUH Report 2009. Available at: http://oas.samhsa. gov/2k9/139/139IDU.htm. Published 2009. Accessed October 22, 2013.
28. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Available at: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm. Published 2013. Accessed October 22, 2013.
29. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New Engl J Med 2012;367(5):423-434. doi:10.1056/NEJMoa1110711.
30. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE Study: A longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991a;109: 75-100.
31. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE study: A longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues 1991b;21:759-776.
32. Vlahov D, Wang C, Ompad D, et al. Mortality risk among recent-onset injection drug users in five US cities. Subst Use Misuse 2008;43(3-4):413-428. doi:10.1080/10826080701203013.
33. Volk RJ, Steinbauer JR, Cantor SB, et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screen for at-risk drinking in primary care patients of different racial/ethnic backgrounds. Addiction 1997;92(2):197-206. doi:10.1111/j.1360-0443.1997.tb03652.x.
34. Yarnall KSH, Pollak KI, Ostbye T, et al. Primary care: is there enough time for prevention? Am J Public Health 2003;93(4):635-641. doi:10.2105/ajph.93.4.635.